4AB:ETR
AbbVie Common Stock
€265.00
arrow_downward
-0.45%(-1.20) 1D
Nov 18, 3:47:04 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€265.60
High
€266.70
Low
€264.60
Mkt. cap
512.01B
Avg. vol.
581.00
Volume
131.00
52-wk high
€272.20
52-wk low
€162.85
No. of employees
57K
Open
€265.60
High
€266.70
Low
€264.60
Mkt. cap
512.01B
Avg. vol.
581.00
Volume
131.00
52-wk high
€272.20
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Abbvie stock price target raised to $349 by Piper Sandler on growth
Zacks Investment Research
·
21 hours ago
How Did AbbVie's Neuroscience Franchise Perform in Q3?
The Globe and Mail
·
1 day ago
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
WSJ
·
2 weeks ago
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com